• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenyl-1,3-oxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Oxazoles Phenyl-1,3-oxazoles

5-(3-Bromophenyl)-1,3-oxazole: An Overview of a Promising Compound (CAS No. 243455-57-4)

5-(3-Bromophenyl)-1,3-oxazole (CAS No. 243455-57-4) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has shown promising potential in various applications, particularly in the development of novel therapeutic agents. In this article, we will delve into the chemical properties, synthesis methods, biological activities, and recent research advancements associated with 5-(3-Bromophenyl)-1,3-oxazole.

Chemical Structure and Properties

5-(3-Bromophenyl)-1,3-oxazole is a heterocyclic compound with a molecular formula of C₉H₆BrNO. The presence of a bromine atom and an oxazole ring imparts unique chemical and physical properties to this molecule. The bromine atom is known for its electron-withdrawing effect, which can influence the reactivity and stability of the compound. The oxazole ring, on the other hand, is a five-membered ring containing one oxygen and one nitrogen atom, which contributes to the compound's aromaticity and biological activity.

The molecular weight of 5-(3-Bromophenyl)-1,3-oxazole is 208.06 g/mol. It is typically a white to off-white solid at room temperature and is soluble in common organic solvents such as dimethyl sulfoxide (DMSO), ethanol, and acetone. These solubility properties make it suitable for various experimental conditions and formulations.

Synthesis Methods

The synthesis of 5-(3-Bromophenyl)-1,3-oxazole can be achieved through several well-established routes in organic chemistry. One common method involves the reaction of 3-bromoaniline with an appropriate carbonyl compound followed by cyclization to form the oxazole ring. Another approach involves the use of microwave-assisted synthesis, which has gained popularity due to its efficiency and reduced reaction times.

A typical synthetic route involves the following steps:

1. N-acylation of 3-bromoaniline with an acyl chloride or acid anhydride to form an intermediate amide.
2. Cyclization of the amide under acidic conditions to form the oxazole ring.
3. Purification of the final product using techniques such as column chromatography or recrystallization.

Biological Activities and Applications

5-(3-Bromophenyl)-1,3-oxazole has been extensively studied for its biological activities, particularly in the context of drug discovery and development. One of its most notable applications is as a scaffold for designing inhibitors of various enzymes and receptors involved in disease pathways.

In recent years, researchers have explored the potential of 5-(3-Bromophenyl)-1,3-oxazole-based compounds as inhibitors of kinases, which are key enzymes involved in signal transduction pathways. For example, a study published in the Journal of Medicinal Chemistry reported that derivatives of 5-(3-Bromophenyl)-1,3-oxazole exhibited potent inhibitory activity against protein kinase C (PKC), a family of enzymes implicated in cancer progression and inflammation.

Beyond kinase inhibition, 5-(3-Bromophenyl)-1,3-oxazole-based compounds have also shown promise as modulators of G protein-coupled receptors (GPCRs). GPCRs are a large family of membrane receptors that play crucial roles in cellular signaling and are targets for numerous therapeutic agents. A study published in Bioorganic & Medicinal Chemistry Letters demonstrated that certain derivatives of 5-(3-Bromophenyl)-1,3-oxazole exhibited high affinity for specific GPCRs, suggesting their potential as lead compounds for drug development.

Clinical Relevance and Future Directions

The clinical relevance of 5-(3-Bromophenyl)-1,3-oxazole-based compounds is evident from their potential applications in treating various diseases. For instance, kinase inhibitors derived from this scaffold have shown promise in preclinical studies for cancer therapy. These inhibitors have demonstrated selective inhibition of cancer-associated kinases while sparing normal cells, thereby reducing toxicity and improving therapeutic outcomes.

In addition to cancer therapy, there is growing interest in exploring the use of these compounds for treating inflammatory diseases such as rheumatoid arthritis and multiple sclerosis. The ability to modulate GPCRs makes them attractive candidates for developing new treatments that target specific signaling pathways involved in these conditions.

Conclusion

5-(3-Bromophenyl)-1,3-oxazole (CAS No. 243455-57-4) is a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and biological activities make it a valuable scaffold for designing novel therapeutic agents. Ongoing research continues to uncover new insights into its mechanisms of action and potential clinical applications. As our understanding deepens, it is likely that this compound will play an increasingly important role in the development of innovative treatments for various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)